CCL18 synergises with high concentrations of glucose in stimulating fibronectin production in human renal tubuloepithelial cells.
BACKGROUND
Diabetic nephropathy is the leading cause of end stage kidney disease worldwide. The pathogenesis of this disease remains elusive and multiple factors have been implicated. These include the effects of hyperglycaemia, haemodynamic and metabolic factors, and an inflammatory process that stimulates cellular signalling pathways leading to disease progression and severe fibrosis. Fibronectin (Fn) is an important protein of the extracellular matrix that is essential in fibrosis and its presence in increased amounts has been identified in the kidney in diabetic nephropathy.


METHODS
Proximal tubuloepithelial (HK-2) cells were stimulated with high glucose (30 mM D-glucose) or glycated albumin (500 μg/mmol) + 4 mM D-glucose or their controls, Mannitol (26 mM + 4 mM D-glucose) and 4 mM D-glucose, respectively. Following 48 h of stimulation the supernatant was collected and MTT [3-(4,5-dimethylthiazole-2,5-diphenyltetrazolium bromide] assay performed to assess cell viability. HK-2 cells were also stimulated in the above environments with recombinant CCL18 (rCCL18) or MCP-1 (rMCP-1) for 48 h with quantification of Fn levels using ELISA.


RESULTS
Co-stimulation of HK-2 cells with high concentrations of glucose and rCCL18 significantly increased Fn (p < 0.001), in comparison to high concentrations of glucose alone. HK-2 cells stimulated with glycated albumin consistently produced Fn and this did not alter following co-stimulation with rCCL18 or rMCP-1.


CONCLUSIONS
This study demonstrates how stimulation with a specific chemokine CCL18 in high glucose upregulates the production of Fn from proximal tubuloepithelial cells. This may be relevant to the development of renal fibrosis in diabetic nephropathy.
Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK. rosa_montero@hotmail.com.
Rosa M
RM
Montero
Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK.
Gurjeet
G
Bhangal
Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK.
Charles D
CD
Pusey
Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK.
Andrew H
AH
Frankel
Renal and Vascular Inflammation Section, Department of Medicine, Imperial College London, Hammersmith Hospital, London, W12 0NN, UK.
Frederick W K
FW
Tam
CCL18; Diabetic nephropathy; Fibronectin; HK-2 cells; MCP-1
Cytokine. 2009 Jul;47(1):37-42
19409809
Am J Physiol Renal Physiol. 2012 Mar 15;302(6):F647-57
22169009
J Am Soc Nephrol. 2015 May;26(5):1115-25
25185988
PLoS One. 2014 May 19;9(5):e97985
24842252
Fibrogenesis Tissue Repair. 2011 Sep 16;4:21
21923916
Am J Respir Cell Mol Biol. 2003 Dec;29(6):743-9
12805086
Arthritis Rheum. 2006 Aug;54(8):2643-55
16868995
J Am Soc Nephrol. 2010 Apr;21(4):556-63
20167701
Curr Diabetes Rev. 2005 Feb;1(1):27-40
18220580
Kidney Int. 2005 Nov;68(5):2111-20
16221210
Chem Pharm Bull (Tokyo). 2013;61(7):688-94
23812394
Mol Biol Cell. 2002 Oct;13(10):3546-59
12388756
Clin Exp Nephrol. 2006 Sep;10(3):186-92
17009076
Am J Physiol Renal Physiol. 2014 Jun 1;306(11):F1327-34
24671333
Gastroenterology. 2004 Aug;127(2):457-69
15300578
Diabetes. 2011 Jun;60(6):1779-88
21521871
J Immunoassay Immunochem. 2010;31(4):279-89
21113841
J Leukoc Biol. 2005 Jul;78(1):14-26
15784687
Histol Histopathol. 2002 Jan;17(1):247-52
11813875
Nephrol Dial Transplant. 2012 Aug;27(8):3049-56
22734110
Vasc Health Risk Manag. 2008;4(3):575-96
18827908
Kidney Int. 2011 Jul;80(1):68-78
21508925
J Am Soc Nephrol. 2003 May;14(5):1358-73
12707406
Contrib Nephrol. 2011;170:124-34
21659765
Nat Rev Nephrol. 2011 Jun;7(6):327-40
21537349
J Cell Sci. 1998 Oct;111 ( Pt 19):2933-43
9730985
Proc Natl Acad Sci U S A. 2006 Dec 5;103(49):18810-5
17121993
J Autoimmun. 2015 Apr;58:111-22
25666976
Lab Invest. 1986 Apr;54(4):394-401
3515046
Scand J Rheumatol. 2009;38(4):282-90
19255934
Kidney Int. 1996 Nov;50(5):1651-8
8914032
Am J Respir Crit Care Med. 2006 Apr 1;173(7):781-92
16415274
J Am Soc Nephrol. 2008 Mar;19(3):433-42
18256353
Respir Med. 2013 Sep;107(9):1444-52
23831213
Clin Exp Pharmacol Physiol. 2007 Oct;34(10):1016-9
17714088
Kidney Int. 2003 Aug;64(2):451-8
12846740
J Am Soc Nephrol. 2007 Apr;18(4):1353-61
17329575
N Engl J Med. 1991 Sep 19;325(12):836-42
1875967
J Immunol. 2003 Apr 1;170(7):3843-9
12646652
Diabetes. 2012 Dec;61(12):3304-13
22872235
Pediatr Nephrol. 2000 Dec;15(3-4):290-301
11149129
Ann N Y Acad Sci. 2006 Nov;1084:89-117
17151295
Diabetes. 2007 Dec;56(12):2982-9
17878288
Am J Pathol. 1995 Nov;147(5):1361-71
7485399